전체 프로그램

ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-4 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved2,047 programs
AntibodyLimited DatastalePfizerPhase 2

Elranatamab + Nirogacestat (Elranatamab + Nirogacestat)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase2#monoclonal-antibody#Pfizer
Trials 1Status Discontinued
AntibodyLimited DatastaleWashington University School of…Phase 2

Elrantamab (Elrantamab)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase2#monoclonal-antibody#Washington
Trials 1Status Recruiting
AntibodyLimited DatastaleMargaret RagniPhase 3

Emicizumab Injection [Hemlibra] (Emicizumab Injection [Hemlibra])

Hemophilia A Without Inhibitor · Hemophilia A Without Inhibitor

#HemophiliaAWithoutInhibitor#Antibody#Phase3#monoclonal-antibody#Margaret
Trials 1Status Discontinued
ADCLimited DatastaleGenmabPhase 2

HuMax-AXL-ADC (Enapotamab vedotin, Enapotamab vedotin (HuMax-AXL-ADC))

Ovarian Cancer; Cervical Cancer · Ovarian Cancer

#OvarianCancer#ADC#Phase2#antibody-drug-conjugate#CervicalCancer+1
Trials 1Status Active
AntibodyLimited DatastaleEli LillyPhase 2

Encorafenib Oral Capsule + Cetuximab (Encorafenib Oral Capsule + Cetuximab)

Colorectal Cancer; BRAF V600E Mutation Positive · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#monoclonal-antibody#BRAFV600EMutationPositive+1
Trials 1Status Recruiting
AntibodyLimited DatastaleMassachusetts General HospitalPhase 3

Encorafenib/Binimetinib/Cetuximab Protocol (Encorafenib/Binimetinib/Cetuximab Protocol)

Metastatic Colon Cancer; Stage III Colon Cancer · Metastatic Colon Cancer

#MetastaticColonCancer#Antibody#Phase3#monoclonal-antibody#StageIIIColonCancer+1
Trials 1Status Recruiting
AntibodyLimited DatastaleSun Yat-sen UniversityPhase 3

trastuzumab (Herceptin, Endocrine therapy combined with trastuzumab)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase3#monoclonal-antibody#Sun
Trials 1Status Active
CGTLimited DatastaleBeijing Immunochina Medical Sci…Phase 1

Engineering of chimeric antigen receptors targeting CD19 in allogeneic T cells (Engineering of chimeric antigen receptors targeting CD19 in allogeneic T cells)

Difficult to Treat Systemic Lupus Erythematosus · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleTCRCure Biopharma Ltd.Phase 1

Enhanced ALPP CAR-T treatment (Enhanced ALPP CAR-T treatment)

Solid Tumor · Solid Tumor

#SolidTumor#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Recruiting
AntibodyLimited DatastaleTianjin Medical University Canc…Preclinical

Enituzumab injection+Abesili tablets+Anastrozole tablets (Enituzumab injection+Abesili tablets+Anastrozole tablets)

Advanced HR+ HER2 Negative Breast Carcinoma · HER2

#HER2#Antibody#Preclinical#monoclonal-antibody#AdvancedHR+HER2NegativeBreastCar+1
Trials 1Status Active
AntibodyLimited DatastaleFox Chase Cancer CenterPhase 2

pembrolizumab (Keytruda, Epacadostat + pembrolizumab)

Recurrent/ Metastatic Endometrial Carcinoma · Recurrent/ Metastatic Endometrial Carcin

#RecurrentMetastaticEndometrialCa#Antibody#Phase2#monoclonal-antibody#Recurrent+2
Trials 1Status Discontinued
AntibodyLimited DatastaleUniversity of Maryland, Baltimo…Phase 2

Erenumab-Aooe (Erenumab-Aooe)

Trigeminal Neuropathy · Trigeminal Neuropathy

#TrigeminalNeuropathy#Antibody#Phase2#monoclonal-antibody#University
Trials 1Status Discontinued
AntibodyLimited DatastaleEli Lilly and CompanyPhase 2

Etesevimab (Etesevimab)

COVID-19 · COVID-19

#COVID-19#Antibody#Phase2#monoclonal-antibody#Eli
Trials 1Status Active
AntibodyLimited DatastaleM.D. Anderson Cancer CenterPhase 2

Etigilimab (Etigilimab)

Ovarian Cancer · Ovarian Cancer

#OvarianCancer#Antibody#Phase2#monoclonal-antibody#MD
Trials 1Status Recruiting
CGTLimited DatastaleSolving Kids' CancerPhase 1

Ex vivo Expanded and Activated Haploidentical Donor NK Cells (Ex vivo Expanded and Activated Haploidentical Donor NK Cells)

Neuroblastoma; Relapsed Neuroblastoma · Neuroblastoma

#Neuroblastoma#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Discontinued
AntibodyLimited DatastaleFundación de Investigación Biom…Preclinical

ustekinumab (Stelara, Ex-vivo stimulation of cells with infliximab, golimumab, adalimumab, vedolizumab and ustekinumab)

Inflammatory Bowel Disease · Inflammatory Bowel Disease

#InflammatoryBowelDisease#Antibody#Preclinical#monoclonal-antibody#Fundacin
Trials 1Status Active
CGTLimited DatastaleM.D. Anderson Cancer CenterPhase 1

Expanded CB-NK cells (Expanded CB-NK cells)

Colon Cancer; Resected Stage · Colon Cancer

#ColonCancer#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Active
CGTLimited DatastaleBaylor College of MedicinePhase 1

Expansion Phase: CD19.CAR/28 and CD19.CAR/28137 T cells (Expansion Phase: CD19.CAR/28 and CD19.CAR/28137 T cells)

Non-Hodgkin Lymphoma; Chronic Lymphocytic Leukemia · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
AntibodyLimited DatastaleRochePhase 3

Experimental Treatment: one course Rituximab/HD-Methotrexate, two courses of MATRix (Experimental Treatment: one course Rituximab/HD-Methotrexate, two courses of MATRix)

Primary Central Nervous System Lymphoma · Primary Central Nervous System Lymphoma

#PrimaryCentralNervousSystemLymph#Antibody#Phase3#monoclonal-antibody#Roche
Trials 1Status Recruiting
AntibodyLimited DatastaleEli LillyPhase 3

Experimental: mXELOX plus cetuximab (Experimental: mXELOX plus cetuximab)

Colo-rectal Cancer · Colo-rectal Cancer

#Colo-rectalCancer#Antibody#Phase3#monoclonal-antibody#Eli
Trials 1Status Active

63 / 103 pages

← PreviousNext →